The company’s treatment appeared to safely lower cholesterol levels in a small trial, giving Verve a chance to rebound from an earlier setback. An experimental ge...

RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial Solutions’ category King of Prussia, PA – April 15th, 2025: Clue...

NeOnc Technologies Holdings, Inc. (Nasdaq Global Market: NTHI), a clinical-stage medical biotechnology company, today announced a strategic partnership with CBCC Glo...

An artificial intelligence model developed by PathAI – used to help diagnose metabolic dysfunction associated steatohepatitis (MASH) from liver biopsy samples – has ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight ga...

Topline data from the single- and multiple-ascending dose studies confirmed safety and favourable tolerability profile of AP02 at all dose levels Full safety, tol...

Cambridge researchers are seeking the views of people with lived experience of dementia – patients and their friends and families – on which existing drugs should be...

The AI-assisted screening tool identified eligible candidates faster and with a higher eligibility rate (20.4% vs 12.7%) than manual screening. Compared with manu...

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence following a prostatectomy. The first p...

Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival...